In addition, the signaling pathways modulated by CLEC11A-related DEGs mainly included FA, proteoglycans in cancer, leukocyte transendothelial migration, ECM–receptor interaction, and complement and coagulation cascade signaling pathways (Figure 4B and Table 2). The gene discussed is CLEC11A; the disease is cancer.